Drug Prices: How US FDA Can Foster Competition Beyond Generic Approvals
Executive Summary
Former FDA Commissioner von Eschenbach and Project HOPE's Wilensky offer related views on how the government could more proactively promote competition with drugs like Shkreli's Daraprim.